ANXA1 and colitis: Most directly, a preclinical study demonstrated that manipulating of AnxA1 levels alters gut microbial composition and modifies susceptibility to DSS-induced colitis, supporting a causal role for AnxA1 in microbiota-host crosstalk (136).